|
|
|
Volumn 3, Issue 2, 2004, Pages 143-147
|
|
Thrombocytopenia after treatment with platelet glycoprotein IIb/IIIa inhibitors.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
ANTITHROMBOCYTIC AGENT;
DRUG DERIVATIVE;
EPITOPE;
EPTIFIBATIDE;
FIBRINOGEN;
FIBRINOGEN RECEPTOR;
HYBRID PROTEIN;
IMMUNOGLOBULIN F(AB) FRAGMENT;
MONOCLONAL ANTIBODY;
PEPTIDE;
TIROFIBAN;
TYROSINE;
ANIMAL;
ANTIBODY SPECIFICITY;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DRUG EFFECT;
HEART INFARCTION;
HUMAN;
IMMUNOLOGY;
METABOLISM;
MOUSE;
REVIEW;
THROMBOCYTE ACTIVATION;
THROMBOCYTOPENIA;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIBODY SPECIFICITY;
CLINICAL TRIALS;
EPITOPES;
FIBRINOGEN;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
MICE;
MYOCARDIAL INFARCTION;
PEPTIDES;
PLATELET ACTIVATION;
PLATELET AGGREGATION INHIBITORS;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
RECOMBINANT FUSION PROTEINS;
THROMBOCYTOPENIA;
TYROSINE;
|
|
EID: 2342548253
PISSN: 15403408
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (20)
|
|
References (41)
|
